Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical companies, like the makers of Xarelto, possess a duty to ensure that their drugs are reasonably safe for use - and failure to perform so may be grounds for compensation. Our lawyers are functioning challenging to acquire these hurt by the drug the compensation they may be entitled to.Whilst bleeding is really a common complication related with anticoagulants, it has been alleged that Xarelto is a lot more hazardous than traditional blood thinners since no antidote exists to reverse its blood-thinning effects. This means that, inside the occasion of an emergency, individuals might be at threat for irreversible bleeding issues, like life-threatening internal and gastrointestinal hemorrhaging.Should you or possibly a loved 1 suffered a critical bleeding occasion after taking Xarelto, you might have legal recourse. For much more data, contact us nowadays to have your case reviewed, free of charge of charge.Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, discomfort and suffering and, in circumstances of death, funeral costs. Furthermore, they may be in search of punitive damages, that are normally awarded to punish the defendant and deter other firms from acting similarly.Why Are Lawsuits Getting Filed?Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs within the lawsuits allege critical and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.The makers of the drug continue to market Xarelto as a safe anticoagulant option.Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.Visit this page for much more information on the alleged health risks of xarelto and nsaids.Multidistrict Litigation Trial Dates SetThe attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.

Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical companies, which includes the makers of Xarelto, have a duty to ensure that their drugs are reasonably safe for use - and failure to do so could be grounds for compensation. Our lawyers are operating hard to obtain these hurt by the drug the compensation they may be entitled to.While bleeding can be a widespread complication connected with anticoagulants, it has been alleged that Xarelto is a lot more hazardous than standard blood thinners since no antidote exists to reverse its blood-thinning effects. This means that, in the event of an emergency, individuals might be at danger for irreversible bleeding problems, like life-threatening internal and gastrointestinal hemorrhaging.If you or even a loved one suffered a significant bleeding event right after taking Xarelto, you may have legal recourse. For far more details, contact us nowadays to possess your case reviewed, totally free of charge.Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for past and future health-related bills, lost wages, discomfort and suffering and, in circumstances of death, funeral expenses. In addition, they're seeking punitive damages, that are typically awarded to punish the defendant and deter other businesses from acting similarly.Why Are Lawsuits Being Filed?Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs within the lawsuits allege serious and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Www.Sbirme.Org Xarelto users than users of certain competitors.The makers of the drug continue to market Xarelto as a secure anticoagulant option.Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user in the event of a bleeding complication.Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.Xarelto is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.Visit this page for far more data on the alleged health risks of Xarelto.Multidistrict Litigation Trial Dates SetThe attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.